Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 11/20 | 0.76 |
| ▸ | CTSK | P43235 | 10/20 | 0.76 |
| ▸ | CTSB | P07858 | 4/20 | 0.76 |
| ▸ | CTSL | P07711 | 2/20 | 0.76 |
| ▸ | AKT1 | P31749 | 1/20 | 0.72 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.60 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2442760 | 0.97 | CTSS (0.76) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL18879622 | 0.96 | CTSS (0.71) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL18879592 | 0.96 | CTSS (0.71) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL17337750 | 0.96 | CTSS (0.71) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2440471 | 0.96 | CTSS (0.71) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2447627 | 0.96 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2442224 | 0.96 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2404125 | 0.96 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2405030 | 0.96 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL2444606 | 0.96 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2365050-B1 | DI-AMIDO GELLANT FOR USE IN CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-08-10 | — | — | EP | claimed |
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | claimed |
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | claimed |
| EP-2365050-A1 | Di-amido gelaant for use in consumer product compositions | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | claimed |
| EP-2365050-B1 | DI-AMIDO GELLANT FOR USE IN CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-08-10 | — | — | EP | disclosed |
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | DAGLA, GNPAT, CDIPT | CTSS 4321/4885CTSK 2957/4885CTSB 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.